Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

99
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
99

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Performance of a quality control center supporting national antimicrobial resistance surveillance.

British journal of biomedical science·2026
Same author

Machine learning based hepatic safety score predicts decompensation in hepatocellular carcinoma systemic therapy.

NPJ digital medicine·2026
Same author

Rapid and sensitive detection of bla<sub>KPC</sub> and bla<sub>NDM</sub> in carbapenemase-producing Enterobacterales using a one-pot recombinase polymerase amplification-CRISPR/Cas12a system with modified protospacer adjacent motifs.

Biosensors & bioelectronics·2026
Same author

IFI35 suppresses the transcription of hepatitis B virus cccDNA minichromosome via promoting HNF4α proteasomal degradation.

Journal of biomedical science·2026
Same author

Shelterin Component TPP1 Drives Tumor Progression and Predicts Poor Prognosis in Hepatocellular Carcinoma.

Biomedicines·2026
Same author

Discovery of pyridomycin derivatives as InhA inhibitors from actinomycetes through molecular networking and an In-House tandem mass library.

Natural products and bioprospecting·2026

Related Experiment Video

Updated: May 6, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.1K

Chronic Hepatitis B Genotype C Mouse Model with Persistent Covalently Closed Circular DNA.

Deok-Hwa Seo1, Wonhee Hur2, Juhee Won3

  • 1The Catholic University Liver Research Center, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.

Viruses
|January 8, 2025
PubMed
Summary

A new mouse model effectively replicates chronic Hepatitis B virus (HBV) infection, enabling study of HBV cccDNA persistence. This breakthrough aids research into therapies targeting the viral DNA reservoir.

Keywords:
Hepatitis B viruscccDNAchronic HBV infectiongenotype Cmouse model

More Related Videos

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.8K

Related Experiment Videos

Last Updated: May 6, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
09:03

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice

Published on: February 3, 2012

19.1K
An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

8.8K
Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
07:25

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice

Published on: September 25, 2019

6.8K

Area of Science:

  • Hepatology
  • Virology
  • Molecular Biology

Background:

  • Chronic Hepatitis B virus (HBV) infection poses significant mortality risks due to cirrhosis and hepatocellular carcinoma (HCC).
  • Covalently closed circular DNA (cccDNA) is a persistent viral DNA reservoir in hepatocytes, driving continuous HBV replication and treatment resistance.
  • Existing animal models inadequately replicate cccDNA dynamics, hindering research into HBV pathogenesis and therapeutics.

Purpose of the Study:

  • To develop and validate a novel mouse model for investigating Hepatitis B virus cccDNA formation and maintenance.
  • To establish a platform for evaluating therapeutic strategies targeting the HBV cccDNA reservoir.

Main Methods:

  • Infection of C57BL/6 mice with recombinant adeno-associated virus (rAAV) carrying a 1.3-overlength HBV genome (genotype C).
  • Assessment of cccDNA levels and viral replication markers (HBsAg, HBeAg, HBV DNA) at various time points.
  • Quantitative PCR (qPCR) with selective DNase treatment and Southern blot analysis for cccDNA detection.

Main Results:

  • Successful establishment of a chronic HBV mouse model with persistent cccDNA expression in hepatocytes.
  • Sustained elevation of serum HBsAg and HBeAg for up to 12 weeks with normal alanine transaminase (ALT) levels.
  • Confirmation of HBV DNA expression and detection of cccDNA using qPCR and Southern blot analysis.

Conclusions:

  • The rAAV-HBV1.3 mouse model effectively recapitulates key aspects of chronic HBV infection, including cccDNA persistence.
  • This model serves as a valuable tool for studying long-term cccDNA maintenance and for preclinical testing of novel anti-HBV therapies targeting cccDNA.